Fetal Growth Pattern in Short Stature Women

Intrauterine Growth Restriction Clinical Trial

Official title:

Fetal Growth Pattern in Short Stature Women as a Model for True Intrauterine Growth Restriction Prediction.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04213443
• Other study ID #: 0275-19-RMB
• Status: Completed
• Start date: December 31, 2020
• Est. completion date: March 11, 2021

Study information

• Verified date: March 2021
• Source: Rambam Health Care Campus
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Women of short stature tend to be classified regarding fetal growth by the same criteria as women of normal and tall stature. The objective of the following study is to evaluate fetal growth patterns parallel to women's height and try to make conclusions regarding possible definitions of subjective Intra-uterine growth restriction.

Description:

Based on a patient registry, women of short stature tend to be classified regarding fetal growth by the same criteria as women of normal and tall stature. The objective of the following study is to evaluate fetal growth patterns parallel to women's height and try to make conclusions regarding possible definitions of subjective Intra-uterine growth restriction. Informed consent is not required due to the retrospective nature of the study. Patient information including medical, obstetric and general background will be collected.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: March 11, 2021
• Est. primary completion date: February 28, 2021
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• Women under 1.6 meters of height.
• Singleton pregnancy.
• Low risk pregnancy.
• Accurate dating.

Exclusion Criteria:

• Women over 1.6 meters of height.
• Multiple pregnancy.
• High risk pregnancy.

Related Conditions & MeSH terms

• Dwarfism
• Fetal Growth Retardation
• Intrauterine Growth Restriction

Intervention

Other:
• Analysis of a patient registry
Analysis of a patient registry.

Locations

Country	Name	City	State
Israel	Rambam health care campus	Haifa

Sponsors (1)

Lead Sponsor	Collaborator
Rambam Health Care Campus

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Estimated fetal weight changes.	Changes in estimated fetal weight during pregnancy.	Up to 1 year from admission.